Chemcon Speciality Chemicals Limited — PPTs, 13-02-2025: Investor Presentation

Q3 FY25 performance highlights show Chemcon Speciality Chemicals Limited achieving total revenue of ₹54.4 crore, reflecting a modest year-on-year growth of 3%. The organic chemicals segment, including HMDC, CMIC, and Bromobenzene, faced challenges due to lower realizations and reduced demand from pharmaceutical and agrochemical sectors. Conversely, the inorganic chemicals division experienced volatility linked to fluctuating crude oil prices. On a positive note, newly introduced organic chemical products are generating interest, with expected approvals in upcoming quarters to serve the import substitution market in India. The company plans to expand its product portfolio at its upcoming P10 and P11 facilities, aiming for a diversified offering to mitigate risks.

Financially, EBITDA for Q3 stood at ₹11.3 crore, representing a significant year-on-year increase of 78%, with an EBITDA margin of 20.8%. Profit After Tax (PAT) surged to ₹8.8 crore, up 98% compared to the previous year, boasting a PAT margin of 16.2%. The trends indicate a positive outlook as the company adapts to market conditions while expanding its operational capabilities.